From: Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir
Blood collection date (mm/dd) | 3/24 | 6/2 | 6/3 | 6/4 | 6/6 | 6/9 | 6/22 | 7/6 | 9/13 | |
---|---|---|---|---|---|---|---|---|---|---|
WBC | (/μL) | 4740 | 10,100 | 13,450 | 10,170 | 10,090 | 4410 | 4950 | 4940 | 4770 |
Neutro | (%) | 56.0 | 79.8 | 88.7 | 85.8 | 83.0 | 56.2 | 79.1 | 45.3 | 43.4 |
AST | (U/L) | 30 | 69 | 68 | 52 | 49 | 55 | 22 | 19 | 16 |
ALT | (U/L) | 43 | 68 | 109 | 103 | 93 | 109 | 30 | 15 | 12 |
LDH | (U/L) | 170 | 941 | 1134 | 916 | 550 | 411 | 224 | 175 | 160 |
CK | (U/L) | 55 | 384 | 501 | 388 | 203 | 81 | 35 | 32 | 57 |
BUN | (mg/dL) | 12.9 | 21.3 | 18.6 | 13.4 | 9.5 | 8.0 | 12.5 | 12.7 | 13.9 |
Cr | (mg/dL) | 0.51 | 0.62 | 0.49 | 0.40 | 0.40 | 0.46 | 0.47 | 0.51 | 0.49 |
CRP | (mg/dL) | 0.05 | 4.20 | 5.45 | 2.52 | 0.69 | 0.35 | 0.05 | 0.04 | 0.02 |
KL-6 | (U/mL) | 303 |